Transitional cell carcinoma
Transitional cell carcinoma
Definition
A malignant neoplasm arising from the transitional epithelium, usually affecting the urinary bladder, ureter, or renal pelvis. It may or may not have a papillary configuration. It is graded 1 to 3 or 4 according to the degree of cellular differentiation and architectural patterns. Grade 1 transitional cell carcinoma is histologically benign but it may recur. Transitional cell carcinomas may also affect the upper respiratory tract and the ovaries.
Also known as carcinoma of transitional epithelial cell, carcinoma of urothelial cell, carcinoma, urothelial, malignant, transitional carcinoma, transitional cell carcinoma, transitional epithelial cell carcinoma, urothelial cell carcinoma — per MONDO
Also identified as
Drugs indicated
| Drug | Relation | Source |
|---|---|---|
| Avelumab | may treat | MEDRT · Public domain (U.S. Government work) |
| Durvalumab | may treat | MEDRT · Public domain (U.S. Government work) |
| Erdafitinib | may treat | MEDRT · Public domain (U.S. Government work) |
| Pembrolizumab | may treat | MEDRT · Public domain (U.S. Government work) |